Related Experiment Videos
Gastrointestinal bleeding associated with myocardial infarction
1Division of Gastroenterology, Maimonides Medical Center, Brooklyn, New York, USA.
Insights
Myocardial infarction (MI) can be missed during severe gastrointestinal (GI) bleeding due to overlapping symptoms. Massive GI bleeding can even trigger MI, but endoscopy is safe for stable patients.
Area of Science:
- Cardiology
- Gastroenterology
Background:
- Gastrointestinal (GI) bleeding and myocardial infarction (MI) can occur concurrently, presenting a complex clinical challenge.
- MI is often underdiagnosed in patients with severe GI bleeding because cardiac symptoms are masked by bleeding-related distress.
- Severe GI bleeding can precipitate MI through mechanisms like hypovolemia and reduced cardiac perfusion.
Purpose of the Study:
- To highlight the distinct clinical syndrome of concurrent GI bleeding and MI.
- To emphasize the diagnostic challenge of recognizing MI in the context of GI bleeding.
- To establish the safety and utility of esophagogastroduodenoscopy in managing these patients.
Main Methods:
- Clinical case review and analysis of patients presenting with both GI bleeding and MI.
- Review of diagnostic criteria and management strategies for concurrent GI bleeding and MI.
- Evaluation of the safety and efficacy of endoscopic procedures in this patient population.
Main Results:
- Concurrent GI bleeding and MI represent a unique syndrome where MI is frequently overlooked.
- Massive GI bleeding can act as a trigger for MI.
- Esophagogastroduodenoscopy is a safe and indicated procedure for evaluating significant upper GI bleeding in clinically stable patients post-MI.
Conclusions:
- Recognition of MI in patients with GI bleeding is critical for appropriate management.
- Endoscopic evaluation is safe and essential for diagnosing upper GI bleeding in patients with a history of MI.
- Understanding the interplay between GI bleeding and MI is crucial for improving patient outcomes.
Abstract:
Gastrointestinal (GI) bleeding associated with myocardial infarcation (MI) often presents as a distinct syndrome that differs from either disease alone. MI is frequently overlooked in the setting of severe GI bleeding because the symptoms and signs of MI are frequently overshadowed by the severe bleeding. GI bleeding, particularly when massive, may precipitate MI from hypovolemia, hemodynamic compromise, and myocardial hypoperfusion. Esophagogastroduodenoscopy is safe in relatively clinically stable patients after MI and is indicated to evaluate significant upper GI bleeding.